Economic Evaluation of a Universal Childhood Pneumococcal Conjugate Vaccination Strategy in Ireland

References

Page 1

	Year	Citations
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Steven Black, Henry R. Shinefield, Bruce Fireman, The Pediatric Infectious Disease Journal	2000	2.3K
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine Cynthia G. Whitney, Monica M. Farley, James L. Hadler, New England Journal of Medicine	2003	2.2K
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media Juhani Eskola, Terhi Kilpi, Arto A. Palmu, New England Journal of Medicine	2001	1.5K
Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant <i>Streptococcus pneumoniae</i> Moe H. Kyaw, Ruth Lynfield, William Schaffner, New England Journal of Medicine	2006	873
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis Carlos G. Grijalva, J. Pekka Nuorti, Patrick G. Arbogast, The Lancet VaccinologyVaccinationPneumonia AdmissionsPneumococcal Conjugate VaccinePediatrics	2007	670
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia Steven Black, Henry R. Shinefield, Stella Ling, The Pediatric Infectious Disease Journal	2002	622
Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage Rosalyn Singleton, Thomas W. Hennessy, Lisa Bulkow, JAMA	2007	616
Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales Alessia Melegaro, W. John Edmunds Vaccine VaccinationPreventive MedicineCost-effectiveness AnalysisHealth EconomicsVaccine Efficacy	2004	211
Cost-Effectiveness of Pneumococcal Conjugate Vaccine G. Thomas Ray, Cynthia G. Whitney, Bruce Fireman, The Pediatric Infectious Disease Journal	2006	162
Pneumococcal pneumonia in the UK—how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV) E. David G. McIntosh, Peter Conway, J Willingham, Vaccine VaccinationPreventive MedicineUk—how Herd ImmunityVaccine EfficacyInfection Control	2004	77

Page 1